Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

Suplatast tosilate is an an immunoregulatory compound. It is formulated as hard gelatin capsules and dry syrup for oral route of administration. It is under development for idiopathic pulmonary ...

Suplatast tosilate is under clinical development by Melius Pharma and currently in Phase II for Idiopathic Pulmonary Fibrosis.

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

Recent findings from the National Institute of Mental Health have introduced a groundbreaking development in anxiety treatment. Mindfulness-based stress reduction (MBSR), a practice that focuses ...